Persistent URL of this record https://hdl.handle.net/1887/115846
In Collections
This item can be found in the following collections:
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)
- All authors
- Kroger, N.; Iacobelli, S.; Franke, G.N.; Platzbecker, U.; Uddin, R.; Hubel, K.; Scheid, C.; Weber, T.; Robin, M.; Stelljes, M.; Afanasyev, B.; Heim, D.; Deliliers, G.L.; Onida, F.; Dreger, P.; Pini, M.; Guidi, S.; Volin, L.; Gunther, A.; Bethge, W.; Poire, X.; Kobbe, G.; Os, M. van; Brand, R.; Witte, T. de
- Date
- 2017-07-01
- Journal
- Journal of Clinical Oncology
- Volume
- 35
- Issue
- 19
- Pages
- 2157 - +